FDA NDC Directory · JSON-LD · Markdown

Divalproex Sodium

NDC 0074-7346 · DRUG FOR FURTHER PROCESSING · TABLET, DELAYED RELEASE

Labeler / ManufacturerAbbVie Inc.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeTABLET, DELAYED RELEASE
Active ingredientsDIVALPROEX SODIUM (250 mg/1)
Marketing started20260922
Package count1

External sources

Source: openFDA. Public-domain (CC0).